The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites
Abstract
The endogenous ligand for the GH secretagogue receptor is ghrelin, a peptide recently purified from the stomach. Ghrelin is n-octanoylated on the Ser3 residue, and this modification is essential for its interaction with the receptor. The degradation of ghrelin by rat and human serum, purified commercial enzymes, and tissues homogenates was analyzed by combining HPLC and mass spectrometry. In serum, ghrelin was desoctanoylated, without proteolysis. The desoctanoylation was significantly reduced by phenylmethylsulfonyl fluoride, a serine proteases and esterases inhibitor. In rat serum, the carboxylesterase inhibitor bis-p-nitrophenyl-phosphate totally inhibited ghrelin desoctanoylation, and a correlation was found between ghrelin desoctanoylation and carboxylesterase activity. Moreover, purified carboxylesterase degraded ghrelin. Thus, carboxylesterase could be responsible for ghrelin desoctanoylation in that species. In human serum, ghrelin desoctanoylation was partially inhibited by eserine salicylate and sodium fluoride, two butyrylcholinesterase inhibitors, but not by bis-p-nitrophenyl-phosphate and EDTA. Purified butyrylcholinesterase was able to degrade ghrelin, and there was a correlation between the butyrylcholinesterase and ghrelin desoctanoylation activities in human sera. This suggested that several esterases, including butyrylcholinesterase, contributed to ghrelin desoctanoylation in human serum. In contact with tissues homogenates, ghrelin was degraded by both desoctanoylation and N-terminal proteolysis. We identified five cleavage sites in ghrelin between residues -Ser2-(acyl)Ser3- (stomach and liver), -(acyl?)Ser3-Phe4- (stomach, liver, and kidney), -Phe4-Leu5- (stomach and kidney), -Leu5-Ser6- and -Pro7-Glu8- (kidney). In all cases, the resulting fragments were biologically inactive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
Howard, A. D., Feighner, S. D., Cully, D. F., Arena, J. P., Liberator, P. A., Rosenblum, C. I., Hamelin, M., Hreniuk, D. L., Palyha, O. C., Anderson, J., et al. (1996) · Science · doi:10.1126/science.273.5277.974 · Cited by 2,073
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin
Asakawa, A., Inui, A., Kaga, O., Yuzuriha, H., Nagata, T., Ueno, N., Makino, S., Fujimiya, M., Niijima, A., Fujino, M. A., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.22158 · Cited by 1,177
Ghrelin and Des-acyl Ghrelin: Two Major Forms of Rat Ghrelin Peptide in Gastrointestinal Tissue
Hosoda, H., Kojima, M., Matsuo, H., & Kangawa, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4039 · Cited by 929
Ghrelin Stimulates Gastric Acid Secretion and Motility in Rats
Masuda, Y., Tanaka, T., Inomata, N., Ohnuma, N., Tanaka, S., Itoh, Z., Hosoda, H., Kojima, M., & Kangawa, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3568 · Cited by 884
THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions
Satoh, T., & Hosokawa, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.257 · Cited by 758
Aldridge, W. N. (1953) · Biochemical Journal · doi:10.1042/bj0530110 · Cited by 741
Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., Fubini, A., Malan, D., Baj, G., Granata, R., Broglio, F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200207165 · Cited by 724
Bednarek, M. A., Feighner, S. D., Pong, S.-S., McKee, K. K., Hreniuk, D. L., Silva, M. V., Warren, V. A., Howard, A. D., Van der Ploeg, L. H. Y., & Heck, J. V. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0001727 · Cited by 561
Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
Kojima, M., Hosoda, H., Matsuo, H., & Kangawa, K. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00362-3 · Cited by 516
Thompson, N. M., Gill, D. A. S., Davies, R., Loveridge, N., Houston, P. A., Robinson, I. C. A. F., & Wells, T. (2004) · Endocrinology · doi:10.1210/en.2003-0899 · Cited by 416
Li, B., Stribley, J. A., Ticu, A., Xie, W., Schopfer, L. M., Hammond, P., Brimijoin, S., Hinrichs, S. H., & Lockridge, O. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.751320.x · Cited by 354
Plasma Ghrelin and Desacyl Ghrelin Concentrations in Renal Failure
Yoshimoto, A., Mori, K., Sugawara, A., Mukoyama, M., Yahata, K., Suganami, T., Takaya, K., Hosoda, H., Kojima, M., Kangawa, K., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032420.12455.74 · Cited by 273
Structure–Activity Relationship of Ghrelin: Pharmacological Study of Ghrelin Peptides
Matsumoto, M., Hosoda, H., Kitajima, Y., Morozumi, N., Minamitake, Y., Tanaka, S., Matsuo, H., Kojima, M., Hayashi, Y., & Kangawa, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5553 · Cited by 254
Cassoni, P., Ghe, C., Marrocco, T., Tarabra, E., Allia, E., Catapano, F., Deghenghi, R., Ghigo, E., Papotti, M., & Muccioli, G. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500173 · Cited by 216
Development of High Affinity Selective VIP1 Receptor Agonists
Gourlet, P., Vandermeers, A., Vertongen, P., Rathe, J., de Neef, P., Cnudde, J., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00228-3 · Cited by 200
Self-citationCardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin
Bedendi, I., Alloatti, G., Marcantoni, A., Malan, D., Catapano, F., Ghé, C., Deghenghi, R., Ghigo, E., & Muccioli, G. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02083-1 · Cited by 180
Ghrelin and Leptin Pulse Discharge in Fed and Fasted Rats
Bagnasco, M. (2002) · Endocrinology · doi:10.1210/en.143.2.726 · Cited by 173
Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with Paraoxonase
Beaumont, N. J., Skinner, V. O., Tan, T., Ramesh, B. S., Byrne, D. J. F., MacColl, G., Keen, J. N., Bouloux, P. M., Mikhailidis, D. P., Bruckdorfer, K. R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200575200 · Cited by 169
Gualillo, O., Lago, F., Gómez-Reino, J. J., Casanueva, F. F., & Diéguez, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00965-7 · Cited by 151
(p-Amidinophenyl)methanesulfonyl fluoride, an irreversible inhibitor of serine proteases
Laura, R., Robison, D. J., & Bing, D. H. (1980) · Biochemistry · doi:10.1021/bi00562a024 · Cited by 104
Morgan, E. W., Yan, B. F., Greenway, D., & Parkinson, A. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1532 · Cited by 82
Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease*
Asthana, S., Greig, N. H., Hegedũs, L., Holloway, H. W., Raffaele, K. C., Schapiro, M. B., & Soncrant, T. T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90246-5 · Cited by 67
Mentlein, R., Rix-Matzen, H., & Heymann, E. (1988) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(88)90032-3 · Cited by 64
Cited by
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.005 · Cited by 1,034
Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., & Lockridge, O. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.002 · Cited by 540
Lockridge, O. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.011 · Cited by 420
The Homeostatic Force of Ghrelin
Yanagi, S., Sato, T., Kangawa, K., & Nakazato, M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.008 · Cited by 321
Liu, J., Prudom, C. E., Nass, R., Pezzoli, S. S., Oliveri, M. C., Johnson, M. L., Veldhuis, P., Gordon, D. A., Howard, A. D., Witcher, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2235 · Cited by 248
Metadata
- Authors
- De Vriese, C., Gregoire, F., Lema-Kisoka, R., Waelbroeck, M., Robberecht, P., & Delporte, C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-11-01
- Volume
- 145
- Issue
- 11
- Pages
- 4997-5005
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1537433484
- Cited by
- 309
- References
- 28
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.